IL160853A0 - Nicotine containing formulations and use thereof - Google Patents
Nicotine containing formulations and use thereofInfo
- Publication number
- IL160853A0 IL160853A0 IL16085302A IL16085302A IL160853A0 IL 160853 A0 IL160853 A0 IL 160853A0 IL 16085302 A IL16085302 A IL 16085302A IL 16085302 A IL16085302 A IL 16085302A IL 160853 A0 IL160853 A0 IL 160853A0
- Authority
- IL
- Israel
- Prior art keywords
- containing formulations
- nicotine containing
- nicotine
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103211A SE0103211D0 (sv) | 2001-09-27 | 2001-09-27 | New formulations and use thereof |
PCT/SE2002/001611 WO2003026655A1 (en) | 2001-09-27 | 2002-09-10 | New formulations and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160853A0 true IL160853A0 (en) | 2004-08-31 |
Family
ID=20285457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16085302A IL160853A0 (en) | 2001-09-27 | 2002-09-10 | Nicotine containing formulations and use thereof |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1429769B1 (sv) |
JP (2) | JP2005504094A (sv) |
KR (1) | KR20040047866A (sv) |
CN (1) | CN100500147C (sv) |
AR (1) | AR036640A1 (sv) |
AT (1) | ATE420642T1 (sv) |
AU (1) | AU2002334522B2 (sv) |
BR (1) | BR0212857A (sv) |
CA (1) | CA2461517C (sv) |
DE (1) | DE60230883D1 (sv) |
DK (1) | DK1429769T3 (sv) |
ES (1) | ES2322847T3 (sv) |
HK (1) | HK1068555A1 (sv) |
IL (1) | IL160853A0 (sv) |
MX (1) | MXPA04002854A (sv) |
NZ (1) | NZ532527A (sv) |
RU (1) | RU2286153C2 (sv) |
SE (1) | SE0103211D0 (sv) |
WO (1) | WO2003026655A1 (sv) |
ZA (1) | ZA200402363B (sv) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0103210D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
SE0103211D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
US7767698B2 (en) | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
SE0300831D0 (sv) * | 2003-03-26 | 2003-03-26 | Pharmacia Ab | New formulations and use therof |
JP4931596B2 (ja) | 2003-11-07 | 2012-05-16 | ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー | タバコ組成物 |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
JP5254616B2 (ja) | 2004-09-13 | 2013-08-07 | クロノ セラピューティクス、インコーポレイテッド | 生物学的同調性(biosynchronous)経皮的薬物送達 |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
GB2468424B (en) * | 2007-04-02 | 2011-11-09 | Parkinson S Inst | Methods and compositions for reduction of side effects of therapeutic treatments |
EP2322166A1 (en) | 2007-04-02 | 2011-05-18 | Parkinson's Institute | Methods and compositions for reduction of side effects of therapeutic treatments |
CN102919738B (zh) | 2007-06-13 | 2016-05-11 | 大塚制药株式会社 | 含雌马酚的提取物、其制备方法、雌马酚的提取方法及含雌马酚的食品 |
CN101439053A (zh) * | 2007-11-22 | 2009-05-27 | 何煜 | 一种中药口腔速释制剂及其制造方法 |
WO2009070978A1 (fr) * | 2007-11-22 | 2009-06-11 | Yu He | Libération rapide dans la cavité buccale des produits de santé et procédé de préparation associé |
US9204667B2 (en) * | 2010-12-01 | 2015-12-08 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products |
US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
CN104338133A (zh) * | 2013-07-24 | 2015-02-11 | 陆媛 | 防治口鼻咽喉上呼吸道感染的嚼服药物组合物及其应用 |
WO2015013679A1 (en) * | 2013-07-26 | 2015-01-29 | Gregory Aharonian | Uses of coca leaf or valerian root to reduce bitterness in foods containing unsweetened cacao |
JP2015084771A (ja) * | 2013-09-24 | 2015-05-07 | アサヒ飲料株式会社 | 容器詰め果汁含有飲料、容器詰め果汁含有飲料の製造方法及び異風味抑制剤 |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
WO2016145373A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
AU2018205529B2 (en) | 2017-01-06 | 2023-08-10 | Morningside Venture Investments Limited | Transdermal drug delivery devices and methods |
MX2020010908A (es) * | 2018-04-16 | 2021-03-25 | Poviva Corp | Composiciones infundidas con compuestos de nicotina y metodos de uso de las mismas. |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8317576D0 (en) * | 1983-06-29 | 1983-08-03 | Shaw A S W | Consumer tobacco products |
GB8615676D0 (en) * | 1986-06-26 | 1986-07-30 | Stoppers Co Ltd | Nicotine containing lozenge |
CA1273878A (en) * | 1987-01-15 | 1990-09-11 | Richard Philip Moody | Nicotine-containing preparation for transdermal administration |
DK615689A (da) * | 1989-11-07 | 1991-05-08 | Anders Dam | Rygesupplement eller rygeerstatningsprodukt |
US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
FR2717387B1 (fr) * | 1994-03-17 | 1996-10-18 | Hi Pharmtech | Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline. |
SE9803986D0 (sv) * | 1998-11-23 | 1998-11-23 | Pharmacia & Upjohn Ab | New compositions |
SE0103211D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
-
2001
- 2001-09-27 SE SE0103211A patent/SE0103211D0/sv unknown
-
2002
- 2002-09-10 NZ NZ532527A patent/NZ532527A/en not_active IP Right Cessation
- 2002-09-10 IL IL16085302A patent/IL160853A0/xx unknown
- 2002-09-10 DK DK02799530T patent/DK1429769T3/da active
- 2002-09-10 ES ES02799530T patent/ES2322847T3/es not_active Expired - Lifetime
- 2002-09-10 EP EP02799530A patent/EP1429769B1/en not_active Expired - Lifetime
- 2002-09-10 AT AT02799530T patent/ATE420642T1/de not_active IP Right Cessation
- 2002-09-10 CN CNB028191609A patent/CN100500147C/zh not_active Expired - Fee Related
- 2002-09-10 WO PCT/SE2002/001611 patent/WO2003026655A1/en active IP Right Grant
- 2002-09-10 MX MXPA04002854A patent/MXPA04002854A/es active IP Right Grant
- 2002-09-10 RU RU2004109153/15A patent/RU2286153C2/ru not_active IP Right Cessation
- 2002-09-10 CA CA002461517A patent/CA2461517C/en not_active Expired - Fee Related
- 2002-09-10 BR BR0212857-8A patent/BR0212857A/pt active Search and Examination
- 2002-09-10 KR KR10-2004-7004471A patent/KR20040047866A/ko not_active Application Discontinuation
- 2002-09-10 JP JP2003530291A patent/JP2005504094A/ja active Pending
- 2002-09-10 DE DE60230883T patent/DE60230883D1/de not_active Expired - Lifetime
- 2002-09-10 AU AU2002334522A patent/AU2002334522B2/en not_active Ceased
- 2002-09-26 AR ARP020103630A patent/AR036640A1/es unknown
-
2004
- 2004-03-25 ZA ZA2004/02363A patent/ZA200402363B/en unknown
-
2005
- 2005-02-08 HK HK05101072.4A patent/HK1068555A1/xx not_active IP Right Cessation
-
2009
- 2009-10-15 JP JP2009238604A patent/JP2010006845A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2003026655A1 (en) | 2003-04-03 |
ZA200402363B (en) | 2005-03-30 |
AR036640A1 (es) | 2004-09-22 |
ES2322847T3 (es) | 2009-06-30 |
CN1561214A (zh) | 2005-01-05 |
JP2010006845A (ja) | 2010-01-14 |
RU2004109153A (ru) | 2005-04-20 |
ATE420642T1 (de) | 2009-01-15 |
CN100500147C (zh) | 2009-06-17 |
EP1429769A1 (en) | 2004-06-23 |
NZ532527A (en) | 2005-09-30 |
JP2005504094A (ja) | 2005-02-10 |
DK1429769T3 (da) | 2009-05-11 |
CA2461517A1 (en) | 2003-04-03 |
SE0103211D0 (sv) | 2001-09-27 |
BR0212857A (pt) | 2004-10-13 |
MXPA04002854A (es) | 2005-06-06 |
DE60230883D1 (de) | 2009-03-05 |
HK1068555A1 (en) | 2005-04-29 |
CA2461517C (en) | 2008-09-02 |
AU2002334522B2 (en) | 2007-05-24 |
EP1429769B1 (en) | 2009-01-14 |
RU2286153C2 (ru) | 2006-10-27 |
KR20040047866A (ko) | 2004-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1068555A1 (en) | New formulations and use thereof | |
GB0009583D0 (en) | Respiratory formulations | |
EP1367060A4 (en) | GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE | |
EP1364957A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE | |
EP1364958A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF | |
IL155071A0 (en) | Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same | |
HUP0204514A3 (en) | Pyridinylimidazoles, pharmaceutical compositions containing them and their use | |
HUP0401911A3 (en) | Pesticidal formulations and their use | |
GB0101035D0 (en) | Formulation and use thereof | |
HUP0300657A3 (en) | Herbicidal composition preparation and use thereof | |
GB0108470D0 (en) | Pharmaceutical compositions and their use | |
HK1069385A1 (en) | Heterocyclic compound and medicinal use thereof | |
EP1370240A4 (en) | NEUROPROTECTOR FORMULATIONS AND METHOD | |
HUP0600436A3 (en) | Catheter composition and uses thereof | |
IL153487A0 (en) | Pharmaceutical compositions and methods for use | |
HUP0401644A3 (en) | Aminobenzoephenones, pharmaceutical compositions containing them and use thereof | |
IL153897A0 (en) | Pharmaceutical compositions and methods for use | |
IL160886A0 (en) | Nicotine containing pharmaceutical formulations and use thereof | |
HUP0303936A3 (en) | Novel composition and use | |
GB0007530D0 (en) | Trityl-type compounds and their use | |
GB0021497D0 (en) | Compounds and their use | |
EP1367123A4 (en) | NEUROTONIN AND ITS USE | |
AUPQ760400A0 (en) | Herbical formulations and methods of use thereof | |
IL162223A0 (en) | 1,3-Diarylprop-2-en-1-ones, compositions containing same and use thereof | |
AU5104101A (en) | Composition and use |